Advances in allergen immunotherapy: Aiming for complete tolerance to allergens
The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Abstract
Allergen-specific immunotherapy is a tolerance-inducing therapy for allergic disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Treg cells play a major role in allergen tolerance and allergen immunotherapy (AIT).371-373”
From International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis (2018) · cites this paper as [373]
Citations
Cites
Asthma phenotypes: the evolution from clinical to molecular approaches
Wenzel, S. E. (2012) · Nature Medicine · doi:10.1038/nm.2678 · Cited by 2,412
Anti-Inflammatory Activity of Human IgG4 Antibodies by Dynamic Fab Arm Exchange
van der Neut Kolfschoten, M., Schuurman, J., Losen, M., Bleeker, W. K., Martínez-Martínez, P., Vermeulen, E., den Bleker, T. H., Wiegman, L., Vink, T., Aarden, L. A., et al. (2007) · Science · doi:10.1126/science.1144603 · Cited by 975
Role of interleukin 10 in specific immunotherapy.
Akdis, C. A., Blesken, T., Akdis, M., Wüthrich, B., & Blaser, K. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2250 · Cited by 973
Jutel, M., Akdis, M., Budak, F., Aebischer‐Casaulta, C., Wrzyszcz, M., Blaser, K., & Akdis, C. A. (2003) · European Journal of Immunology · doi:10.1002/eji.200322919 · Cited by 915
The 3 major types of innate and adaptive cell-mediated effector immunity
Annunziato, F., Romagnani, C., & Romagnani, S. (2015) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.11.001 · Cited by 818
Immunoglobulin G4: an odd antibody
Aalberse, R. C., Stapel, S. O., Schuurman, J., & Rispens, T. (2009) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2009.03207.x · Cited by 818
Ling, E. M., Smith, T., Nguyen, X. D., Pridgeon, C., Dallman, M., Arbery, J., Carr, V. A., & Robinson, D. S. (2004) · The Lancet · doi:10.1016/s0140-6736(04)15592-x · Cited by 747
van de Veen, W., Stanic, B., Yaman, G., Wawrzyniak, M., Söllner, S., Akdis, D. G., Rückert, B., Akdis, C. A., & Akdis, M. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.01.014 · Cited by 652
Self-citationImmunotherapy with a Ragweed–Toll-Like Receptor 9 Agonist Vaccine for Allergic Rhinitis
Creticos, P. S., Schroeder, J. T., Hamilton, R. G., Balcer-Whaley, S. L., Khattignavong, A. P., Lindblad, R., Li, H., Coffman, R., Seyfert, V., Eiden, J. J., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052916 · Cited by 562
Akdis, C. A., Bachert, C., Cingi, C., Dykewicz, M. S., Hellings, P. W., Naclerio, R. M., Schleimer, R. P., & Ledford, D. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.02.036 · Cited by 538
Cited by
Akdis, C. A. (2021) · Nature Reviews Immunology · doi:10.1038/s41577-021-00538-7 · Cited by 981
Akdis, M., Aab, A., Altunbulakli, C., Azkur, K., Costa, R. A., Crameri, R., Duan, S., Eiwegger, T., Eljaszewicz, A., Ferstl, R., et al. (2016) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2016.06.033 · Cited by 912
International consensus statement on allergy and rhinology: Allergic rhinitis – 2023
Wise, S. K., Damask, C., Roland, L. T., Ebert, C., Levy, J. M., Lin, S., Luong, A., Rodriguez, K., Sedaghat, A. R., Toskala, E., et al. (2023) · International Forum of Allergy & Rhinology · doi:10.1002/alr.23090 · Cited by 507
International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis
Wise, S. K., Lin, S. Y., Toskala, E., Orlandi, R. R., Akdis, C. A., Alt, J. A., Azar, A., Baroody, F. M., Bachert, C., Canonica, G. W., et al. (2018) · International Forum of Allergy & Rhinology · doi:10.1002/alr.22073 · Cited by 557
Mechanisms of allergen immunotherapy for inhaled allergens and predictive biomarkers
Shamji, M. H., & Durham, S. R. (2017) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2017.10.010 · Cited by 446
Shamji, M. H., Kappen, J. H., Akdis, M., Jensen‐Jarolim, E., Knol, E. F., Kleine‐Tebbe, J., Bohle, B., Chaker, A. M., Till, S. J., Valenta, R., et al. (2017) · Allergy · doi:10.1111/all.13138 · Cited by 382
“• Tregs appear very early in the treatment long before it is possible to evaluate clinical efficacy, so it remains difficult to use Tregs as a predictive biomarker in AIT in the absence of analysis of responders vs nonresponders.”
BackgroundMechanisms of immune regulation in allergic diseases: the role of regulatory T and B cells
Palomares, O., Akdis, M., Martín‐Fontecha, M., & Akdis, C. A. (2017) · Immunological Reviews · doi:10.1111/imr.12555 · Cited by 330
Self-citationSampson, H. A., O'Mahony, L., Burks, A. W., Plaut, M., Lack, G., & Akdis, C. A. (2018) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2017.11.005 · Cited by 298
Han, H., Roan, F., & Ziegler, S. F. (2017) · Immunological Reviews · doi:10.1111/imr.12546 · Cited by 285
Role of regulatory B cells in immune tolerance to allergens and beyond
van de Veen, W., Stanic, B., Wirz, O. F., Jansen, K., Globinska, A., & Akdis, M. (2016) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2016.07.006 · Cited by 258
“2 Studies involving allergic patients undergoing allergen immunotherapy (AIT) have also provided valuable insight into the mechanisms underlying tolerance induction to allergens.(3) The term regulatory B (Breg) cell is used as an umbrella term that comprises the different immunosuppressive B-cell subsets that have bee…”
BackgroundSelf-citationAdvances and highlights in biomarkers of allergic diseases
Ogulur, I., Pat, Y., Ardicli, O., Barletta, E., Cevhertas, L., Fernandez‐Santamaria, R., Huang, M., Bel Imam, M., Koch, J., Ma, S., et al. (2021) · Allergy · doi:10.1111/all.15089 · Cited by 235
Mechanisms of allergen-specific immunotherapy
Głobińska, A., Boonpiyathad, T., Satitsuksanoa, P., Kleuskens, M., van de Veen, W., Sokolowska, M., & Akdis, M. (2018) · Annals of Allergy, Asthma & Immunology · doi:10.1016/j.anai.2018.06.026 · Cited by 132
Sirvent, S., Soria, I., Cirauqui, C., Cases, B., Manzano, A. I., Diez-Rivero, C. M., Reche, P. A., López-Relaño, J., Martínez-Naves, E., Cañada, F. J., et al. (2016) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2016.02.029 · Cited by 119
Eljaszewicz, A., Ruchti, F., Radzikowska, U., Głobińska, A., Boonpiyathad, T., Gschwend, A., Morita, H., Helbling, A., Arasi, S., Kahlert, H., et al. (2020) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2020.08.042 · Cited by 120
“Three types of comparisons were made: (1) first-year time points were compared with baseline, (2) third-year time points after initiation of AIT were compared with the first-year time points; and (3) patients with allergy were compared with the healthy controls at the same time points.”
ResultIL-33 dysregulates regulatory T cells and impairs established immunologic tolerance in the lungs
Chen, C.-C., Kobayashi, T., Iijima, K., Hsu, F.-C., & Kita, H. (2017) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2017.01.015 · Cited by 111
Breiteneder, H., Diamant, Z., Eiwegger, T., Fokkens, W. J., Traidl‐Hoffmann, C., Nadeau, K., O’Hehir, R. E., O’Mahony, L., Pfaar, O., Torres, M. J., et al. (2019) · Allergy · doi:10.1111/all.13851 · Cited by 107
New Therapies for Asthma and Chronic Obstructive Pulmonary Disease
Gross, N. J., & Barnes, P. J. (2017) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201610-2074pp · Cited by 111
“Alternatively, novel, more effective approaches to immunotherapy may be developed (49).”
BackgroundIntralymphatic Immunotherapy: Update and Unmet Needs
Senti, G., Freiburghaus, A. U., Larenas-Linnemann, D., Hoffmann, H. J., Patterson, A. M., Klimek, L., Di Bona, D., Pfaar, O., Ahlbeck, L., Akdis, M., et al. (2019) · International Archives of Allergy and Immunology · doi:10.1159/000493647 · Cited by 103
Synchronous immune alterations mirror clinical response during allergen immunotherapy
Renand, A., Shamji, M. H., Harris, K. M., Qin, T., Wambre, E. R., Scadding, G. W., Würtzen, P. A., Till, S. J., Togias, A. G., Nepom, G. T., et al. (2017) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2017.09.041 · Cited by 99
Der p 1‐specific regulatory T‐cell response during house dust mite allergen immunotherapy
Boonpiyathad, T., Sokolowska, M., Morita, H., Rückert, B., Kast, J. I., Wawrzyniak, M., Sangasapaviliya, A., Pradubpongsa, P., Fuengthong, R., Thantiworasit, P., et al. (2019) · Allergy · doi:10.1111/all.13684 · Cited by 93
Heeringa, J. J., McKenzie, C. I., Varese, N., Hew, M., Bakx, A. T. C. M., Aui, P. M., Rolland, J. M., O’Hehir, R. E., & van Zelm, M. C. (2020) · Allergy · doi:10.1111/all.14073 · Cited by 92
Hylander, T., Larsson, O., Petersson-Westin, U., Eriksson, M., Kumlien Georén, S., Winqvist, O., & Cardell, L.-O. (2016) · Respiratory Research · doi:10.1186/s12931-016-0324-9 · Cited by 92
“The golden standard treatment is subcutaneous immunotherapy (SCIT), which shows long-term benefit for the treatment of allergic rhinitis, conjunctivitis and asthma [3, 4].”
BackgroundTransdermal immunomodulation: Principles, advances and perspectives
Zhao, Z., Ukidve, A., Dasgupta, A., & Mitragotri, S. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.03.010 · Cited by 92
Applications and mechanisms of immunotherapy in allergic rhinitis and asthma
Kappen, J. H., Durham, S. R., Veen, H. I. ’., & Shamji, M. H. (2016) · Therapeutic Advances in Respiratory Disease · doi:10.1177/1753465816669662 · Cited by 94
“Several studies have suggested that there is an overlap between these subsets of Treg cells in immunomodulating properties [Akdis and Akdis, 2015].”
BackgroundInfluentialToward precision medicine and health: Opportunities and challenges in allergic diseases
Galli, S. J. (2016) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2016.03.006 · Cited by 85
The External Exposome and Allergies: From the Perspective of the Epithelial Barrier Hypothesis
Sözener, Z. Ç., Yücel, Ü. Ö., Altıner, S., Öztürk, B. Ö., Çerçi, P., Türk, M., Akin, B. G., Akdiş, M., Yılmaz, İ., Özdemir, C., et al. (2022) · Frontiers in Allergy · doi:10.3389/falgy.2022.887672 · Cited by 80
“The third function is immune suppression, which includes cells and cytokines that are related to the suppression of inflammation, such as the generation of regulatory dendritic cells (DCs), Treg and Breg cells and their suppressor cytokines (45).”
BackgroundMondoulet, L., Dioszeghy, V., Busato, F., Plaquet, C., Dhelft, V., Béthune, K., Leclere, L., Daviaud, C., Ligouis, M., Sampson, H. A., et al. (2018) · Allergy · doi:10.1111/all.13479 · Cited by 80
Mechanisms Underlying Induction of Tolerance to Foods
Berin, M. C., & Shreffler, W. G. (2015) · Immunology and Allergy Clinics of North America · doi:10.1016/j.iac.2015.08.002 · Cited by 71
The role of regulatory B cells in allergen immunotherapy
van de Veen, W. (2017) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/aci.0000000000000400 · Cited by 67
“Hallmarks of a healthy response to allergens are induction of IL-10-producing inducible type 1 regulatory T (TR1) cells and blocking IgG(4) antibodies [37].”
BackgroundThe concepts of asthma endotypes and phenotypes to guide current and novel treatment strategies
Özdemir, C., Küçüksezer, U. C., Akdiş, M., & Akdiş, C. A. (2018) · Expert Review of Respiratory Medicine · doi:10.1080/17476348.2018.1505507 · Cited by 69
Hesse, L., van Ieperen, N., Habraken, C. M., Petersen, A. H., Korn, S., Smilda, T., Goedewaagen, B., Ruiters, M. H. J., van der Graaf, A. C., & Nawijn, M. C. (2018) · Allergy · doi:10.1111/all.13382 · Cited by 59
“Pro-inflammatory activation of the antigen-presenting cell during SCIT might also negatively influence the induction of a tolerogenic T-cell response.(25) However, some studies have reported successful use of TLR agonists as adjuvants for allergen immunotherapy, including monophosphoryl lipid A(26) or bacterial DNA ri…”
BackgroundEdwards, M. R., Saglani, S., Schwarze, J., Skevaki, C., Smith, J. A., Ainsworth, B., Almond, M., Andreakos, E., Belvisi, M. G., Chung, K. F., et al. (2017) · European Respiratory Journal · doi:10.1183/13993003.02448-2016 · Cited by 55
Palomares, F., Gómez, F., Bogas, G., Campo, P., Perkins, J. R., Díaz‐Perales, A., Rodríguez, M. J., Prieto, A., Barber, D., Torres, M. J., et al. (2017) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201700669 · Cited by 55
Montamat, G., Leonard, C., Poli, A., Klimek, L., & Ollert, M. W. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.590054 · Cited by 57
“Dysregulation of immune tolerance may lead to immune-mediated diseases such as autoimmunity, cancer and various immediate-type allergic disorders (4, 5).”
BackgroundXu, S., Kong, Y., Jiao, W.-E., Yang, R., Qiao, Y.-L., Xu, Y., Tao, Z., & Chen, S. (2019) · International Immunopharmacology · doi:10.1016/j.intimp.2019.04.039 · Cited by 53
Tolerance mechanisms of allergen immunotherapy
van de Veen, W., & Akdis, M. (2020) · Allergy · doi:10.1111/all.14126 · Cited by 46
The Use of Biomarkers to Predict Aero-Allergen and Food Immunotherapy Responses
Sindher, S. B., Long, A., Acharya, S., Sampath, V., & Nadeau, K. C. (2018) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-018-8678-z · Cited by 44
Zhang, Z., Li, Z., & Lin, H. (2021) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.1c03953 · Cited by 44
Microneedle delivery of autoantigen for immunotherapy in type 1 diabetes
Zhao, X. Y., Birchall, J. C., Coulman, S. A., Tatović, D., Singh, R., Li, W., Wong, F. S., Dayan, C. M., & Hanna, S. J. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.12.040 · Cited by 48
“Previous studies have shown that epicutaneous antigen administration can be tolerogenic in the context of allergies [54,55] and autoimmune disease [56,57].”
BackgroundToll-like receptors as targets for allergen immunotherapy
Aryan, Z., & Rezaei, N. (2015) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/aci.0000000000000212 · Cited by 45
“Allergen immunotherapy delivers increasing doses of allergens to the immune system and thereby induces immune-regulatory responses and promotes tolerance induction [5].”
BackgroundSchistosoma japonicum peptide SJMHE1 suppresses airway inflammation of allergic asthma in mice
Zhang, W., Li, L., Zheng, Y., Xue, F., Mengzhu, Y., Ma, Y., Dong, L., Shan, Z., Feng, D., Wang, T., et al. (2019) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14661 · Cited by 43
Helminth-induced regulatory T cells and suppression of allergic responses
Logan, J., Navarro, S., Loukas, A., & Giacomin, P. (2018) · Current Opinion in Immunology · doi:10.1016/j.coi.2018.05.007 · Cited by 38
Sialylation of IgG antibodies inhibits IgG-mediated allergic reactions
Epp, A., Hobusch, J., Bartsch, Y. C., Petry, J., Lilienthal, G., Koeleman, C. A. M., Eschweiler, S., Möbs, C., Hall, A., Morris, S. C., et al. (2017) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2017.06.021 · Cited by 42
Tsai, M., Starkl, P., Marichal, T., & Galli, S. J. (2015) · Current Opinion in Immunology · doi:10.1016/j.coi.2015.07.001 · Cited by 38
“In how many ways can the immune response detect such challenges? Can other MC-derived mediators, beyond proteases and perhaps heparin, confer benefit in such settings? Can IgE enhance adaptive resistance to venoms by mechanisms other than those involving MCs? And what are the genetic or environmental factors which det…”
Sokołowska, M., Głobińska, A., & Akdiş, C. A. (2017) · Wiley-VCH eBooks · doi:10.1002/9783527692156.ch38 · Cited by 40
Coltherd, J. C., Rodgers, D. T., Lawrie, R. E., Al-Riyami, L., Suckling, C. J., Harnett, W., & Harnett, M. M. (2016) · Scientific Reports · doi:10.1038/srep19224 · Cited by 36
Hong-ying, L., Li, T., Zhao, J., Qin, J., Zeng, G., Cai, S., Li, Y., Zhang, J., & Chen, H. (2016) · Scientific Reports · doi:10.1038/srep20481 · Cited by 39
Basophil biomarkers as useful predictors for sublingual immunotherapy in allergic rhinitis
Caruso, M., Cibella, F., Emma, R., Campagna, D., Tringali, G., Amaradio, M. D., & Polosa, R. (2018) · International Immunopharmacology · doi:10.1016/j.intimp.2018.04.034 · Cited by 38
Recent developments and highlights in immune monitoring of allergen immunotherapy
van Zelm, M. C., McKenzie, C. I., Varese, N. P., Rolland, J. M., & O’Hehir, R. E. (2019) · Allergy · doi:10.1111/all.14078 · Cited by 40
Landers, J. J., Janczak, K. W., Shakya, A. K., Zarnitsyn, V. G., Patel, S. R., Baker, J. R., Gill, H. S., & O’Konek, J. J. (2022) · Immunotherapy · doi:10.2217/imt-2021-0206 · Cited by 38
Wang, M., Zhao, N., Wang, C., Jin, Z., & Zhang, L. (2023) · Allergy · doi:10.1111/all.15729 · Cited by 36
Mechanisms of Aeroallergen Immunotherapy
Özdemir, C., Küçüksezer, U. C., Akdiş, M., & Akdiş, C. A. (2015) · Immunology and Allergy Clinics of North America · doi:10.1016/j.iac.2015.08.003 · Cited by 40
The Use of Adjuvants for Enhancing Allergen Immunotherapy Efficacy
Chesné, J., Schmidt‐Weber, C. B., & Bieren, J. E. (2015) · Immunology and Allergy Clinics of North America · doi:10.1016/j.iac.2015.08.009 · Cited by 33
Guan, K., Liu, B., Wang, M., Li, Z., Chang, C. C.-C., Cui, L., Wang, R.-Q., Wen, L.-P., Leung, P. S. C., Wei, J., et al. (2019) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-019-08751-y · Cited by 32
Wang, K., Zheng, R., Chen, Y., Yu, Q., Zhong, H., Xiao, P., Wang, Y., & Tang, J. (2019) · American Journal of Otolaryngology · doi:10.1016/j.amjoto.2019.102280 · Cited by 29
Promises and challenges of mucosal COVID-19 vaccines
Rathore, A. P. S., & John, A. L. S. (2023) · Vaccine · doi:10.1016/j.vaccine.2023.04.013 · Cited by 35
“In some contexts, such as allergen immunotherapies, repeated exposure to antigens can re-establish tolerance [98].”
BackgroundThe Multifaceted B Cell Response in Allergen Immunotherapy
Jiménez‐Saiz, R., & Patil, S. U. (2018) · Current Allergy and Asthma Reports · doi:10.1007/s11882-018-0819-1 · Cited by 29
Precision/Personalized Medicine in Allergic Diseases and Asthma
Küçüksezer, U. C., Özdemir, C., Akdiş, M., & Akdiş, C. A. (2018) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-018-0526-6 · Cited by 28
Altman, M. C., Segnitz, R. M., LARSON, D. L., Jayavelu, N. D., Smith, M. T., Patel, S., Scadding, G. W., Qin, T., Sanda, S., Steveling, E. H., et al. (2023) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2023.06.025 · Cited by 27
Gotoh, M., Kaminuma, O., Nakaya, A., Katayama, K., Motoi, Y., Watanabe, N., Saeki, M., Nishimura, T., Kitamura, N., Yamaoka, K., et al. (2017) · International Immunology · doi:10.1093/intimm/dxx034 · Cited by 26
Investigation of glycated shrimp tropomyosin as a hypoallergen for potential immunotherapy
Zhang, Z., Li, X.-M., Li, Z., & Lin, H. (2021) · Food & Function · doi:10.1039/d0fo03039b · Cited by 26
Feng, S., Song, G., Liu, L., Liu, W., Liang, G., & Song, Z. (2022) · The Journal of Dermatology · doi:10.1111/1346-8138.16582 · Cited by 26
O’Konek, J. J., Landers, J. J., Janczak, K. W., Lindsey, H. K., Mondrusov, A. M., Totten, T. D., & Baker, J. R. (2019) · Allergy · doi:10.1111/all.14064 · Cited by 26
Mechanisms of Allergen Immunotherapy Supporting its Disease-Modifying Effect
Bumbăcea, R. S., Boustani, R., Panaitescu, C. B., Haidar, L., Buzan, M. R., Bumbăcea, D., Laculiceanu, A. G., Cojanu, C., Spanu, D. E., & Agache, I. O. (2022) · Immunotherapy · doi:10.2217/imt-2021-0325 · Cited by 23
Mechanism and clinical evidence of immunotherapy in allergic rhinitis
Carli, M., Capezzali, E., Tonon, S., & Frossi, B. (2023) · Frontiers in Allergy · doi:10.3389/falgy.2023.1217388 · Cited by 24
“As mentioned above, a key role in the context of AIT is played by IL-10 which, following therapy, is produced in high amounts by T lymphocytes along with other suppressive cytokines (such as TGF-β and IL-35), driving the generation of a tolerogenic immune phenotype: Treg1 cell proliferation, inhibition of Th2 response…”
BackgroundPelaia, C., Vatrella, A., Lombardo, N., Terracciano, R., Navalesi, P., Savino, R., & Pelaia, G. (2017) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2018.1402003 · Cited by 23
“basophils, and eosinophils (Figure 3) [59].”
Biomarkers of immunotherapy response in patients with allergic rhinitis
Licari, A., Castagnoli, R., Brambilla, I., Tosca, M. A., Filippo, M. D., Marseglia, G. L., & Ciprandi, G. (2018) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2018.1504679 · Cited by 23
“One of the major alterations in the course of AIT is the modulation of allergen-specific B cells in the direction of Breg cells [53,54].”
BackgroundKatayama, S., Yamaguchi, D., Suzuki, Y., Alathamneh, A., Mitani, T., Satoh, R., Teshima, R., Mine, Y., & Nakamura, S. (2018) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201800303 · Cited by 24
Limited impact of Der p 23 IgE on treatment outcomes in tablet allergy immunotherapy phase III study
Stranzl, T., Ipsen, H., Christensen, L. H., Eiwegger, T., Johansen, N., Lund, K., & Andersen, P. S. (2020) · Allergy · doi:10.1111/all.14200 · Cited by 21
Zhao, J., He, P., Jiang, M., He, C., Zhao, Y., Zhang, Z., Zhang, Z., Du, G., & Sun, X. (2024) · Journal of Controlled Release · doi:10.1016/j.jconrel.2024.01.018 · Cited by 21
van Zelm, M. C., McKenzie, C. I., Varese, N. P., Rolland, J. M., & O’Hehir, R. E. (2021) · Allergy · doi:10.1111/all.15036 · Cited by 20
Yang, H., Chen, H., Jin, M., Xie, H., He, S., & Wei, J. (2016) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2016.2793 · Cited by 20
“Numerous studies have shown that crude allergen extracts currently used in SIT are clinically effective (54-56); a high allergen dose is more effective, although the potential risk of severe acute side-effects is a limiting factor.”
BackgroundImmune monitoring for precision medicine in allergy and asthma
Boyd, S. D., Hoh, R. A., Nadeau, K. C., & Galli, S. J. (2017) · Current Opinion in Immunology · doi:10.1016/j.coi.2017.08.007 · Cited by 20
“Ideally, detailed patient phenotyping could help tailor the allergen dose escalation schedule for AIT for allergic rhinitis [73 ,74,75] or oral immunotherapy (OIT) for food allergies, and predict which patients will become permanently desensitized or tolerized [76–78] rather than achieving desensitization dependent on…”
Immunotherapy: Making the case for precision medicine
Bluestone, J. A., & Tang, Q. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aaa9846 · Cited by 24
Allergen immunotherapy in asthma: current evidence
Novakova, P. I., Tiotiu, A. I., Baiardini, I., Krusheva, B., Chong‐Neto, H. J., & Novakova, S. M. (2019) · Journal of Asthma · doi:10.1080/02770903.2019.1684517 · Cited by 18
Allergen-specific Immunotherapy for Inhalant Allergens in Children
Caffarelli, C., Cangemi, J., Mastrorilli, C., Giannetti, A., & Ricci, G. (2019) · Current Pediatric Reviews · doi:10.2174/1573396315666191021104003 · Cited by 20
How the Immune System Responds to Allergy Immunotherapy
Veneziani, I., Landolina, N., Ricci, B., Rossi, O., Moretta, L., & Maggi, E. (2022) · Biomedicines · doi:10.3390/biomedicines10112825 · Cited by 17
Sun, W., Pan, L., Yu, Q., Sun, Y., Zeng, X., Bai, X., & Li, M. (2018) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2018.1482171 · Cited by 16
“And this decrease in tIgE does not relate to improvement of clinical symptoms.(21)”
BackgroundCell Therapy for Prophylactic Tolerance in Immunoglobulin E-mediated Allergy
Baranyi, U., Farkas, A. M., Hock, K., Mahr, B., Linhart, B., Gattringer, M., Focke-Tejkl, M., Petersen, A., Wrba, F., Rülicke, T., et al. (2016) · EBioMedicine · doi:10.1016/j.ebiom.2016.03.028 · Cited by 17
“, 2006), and also other mechanisms, such as induction of regulatory cells, including Tregs and Bregs, were described (Akdis and Akdis, 2015).”
BackgroundOhashi‐Doi, K., Lund, K., Mitobe, Y., & Okamiya, K. (2019) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b19-00093 · Cited by 14
Preclinical safety and immunological efficacy of Alternaria alternata polymerized extracts
Morales, M., Gallego, M. T., Iraola, V. M., Moya, R., Santana, S., & Carnés, J. (2017) · Immunity Inflammation and Disease · doi:10.1002/iid3.212 · Cited by 15
“In that sense, AIT should have the capacity to induce changes in the polarization of allergen-specific T cells (cellular immune response) and an increase in the production of blocking antibodies against offending allergens, among other effects (humoral immune response [35]).”
InfluentialJones, A. C., Anderson, D. R., Troy, N. M., Mallon, D., Hartmann, R., Serralha, M., Holt, B. J., Bosco, A., & Holt, P. G. (2020) · Allergy · doi:10.1111/all.14265 · Cited by 12
Subcutaneous and Sublingual Immunotherapy in a Mouse Model of Allergic Asthma
Hesse, L., & Nawijn, M. C. (2017) · Methods in molecular biology · doi:10.1007/978-1-4939-6786-5_11 · Cited by 12
HLA‐II genes are associated with outcomes of specific immunotherapy for allergic rhinitis
Zhao, Y., Zhao, Y., Zhang, Y., & Zhang, L. (2019) · International Forum of Allergy & Rhinology · doi:10.1002/alr.22384 · Cited by 12
Pathophysiology of Allergic Rhinitis
Ceylan, M. E., Cingi, C., Özdemir, C., Küçüksezer, U. C., & Akdiş, C. A. (2019) · Springer eBooks · doi:10.1007/978-3-030-21217-9_32 · Cited by 14
Kunz, S., Dolch, A., Surianarayanan, S., Dorn, B., Bewersdorff, M., Alessandrini, F., Behrendt, R., Karp, C. L., Müller, W., Martin, S. F., et al. (2016) · European Journal of Immunology · doi:10.1002/eji.201646319 · Cited by 10
Serum IgE as biomarker for predicting allergen immunotherapy effectiveness
Ciprandi, G. (2017) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2016.12.987 · Cited by 10
Corthésy, B., & Bioley, G. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.07.019 · Cited by 9
Pharmacoeconomics of Biologic Therapy
Bukstein, D. A., & Luskin, A. T. (2017) · Immunology and Allergy Clinics of North America · doi:10.1016/j.iac.2017.01.011 · Cited by 10
Recall Urticaria: Aspirin Also Induces It
Cimbollek, S., Ávila-Castellano, M., Labella, M., Baynova, K., Mera, T. D. A., & Quiralte, J. (2018) · Journal of Investigational Allergology and Clinical Immunology · doi:10.18176/jiaci.0219 · Cited by 9
Hypersensitivity: IgE ‐Mediated (Type I )
Delves, P. J. (2017) · Wiley eBooks · doi:10.1002/9780470015902.a0000965.pub3 · Cited by 8
Wang, Y., Zhang, L., Shi, B., & Luo, J. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1443954 · Cited by 7
“Understanding these mechanisms can lead to the development of more effective and personalized treatment strategies, thereby improving patient outcomes and reducing the economic burden associated with the disease (10 – 12).”
BackgroundZhang, K., Kim, S. M., Kwon, H., Kim, S. H., Kim, T., Sun, Z., Kim, H. L., Tyo, A., Kim, J. H., Kim, R. G., et al. (2025) · Science Translational Medicine · doi:10.1126/scitranslmed.ado1375 · Cited by 6
Key Points for Moving the Endotypes Field Forward
Sugita, K., Sokołowska, M., & Akdiş, C. A. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-813471-9.00020-7 · Cited by 6
The role of air pollution in fetal origins of childhood allergy: Challenges and opportunities
Deng, Q., Liu, L., Cheng, X., Xue, Y., Li, M., Liu, X., & Feng, F. (2023) · Current Opinion in Environmental Science & Health · doi:10.1016/j.coesh.2023.100474 · Cited by 5
Advances in patent applications related to allergen immunotherapy
da Silva, E. S., Pinheiro, C. S., Quintella, C. M. A. L. T. D. M. H., Ferreira, F., Pacheco, L. G. C., & Alcântara‐Neves, N. M. (2016) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.2016.1170809 · Cited by 5
“allergy-associated symptoms, during 3 to 5 years of treatment.[7] The effect of SIT is long-lasting and protects the”
BackgroundAllergen Immunotherapy in Pediatric Respiratory Allergy
Doroudchi, A., Imam, K. H., & Lloret, M. I. G. (2021) · Current Treatment Options in Allergy · doi:10.1007/s40521-021-00280-4 · Cited by 4
Qin, Y., Huang, W., Zheng, R., Wang, Q., Yu, Q., Li, Y., Wang, K., & Tang, J. (2024) · Clinical and Translational Allergy · doi:10.1002/clt2.12341 · Cited by 4
“1 2–5 In 2008, the Senti first reported a clinical trial of inguinal lymph node injection immunotherapy (ILIT).”
BackgroundRhinology Future Debates 2017 by EUFOREA : Novel treatments and surgical solutions in rhinology
Fokkens, W. J., Pugin, B., Bachert, C., Bousquet, J. J., Joos, G., Louis, R. E., Pilette, C., Pfaar, O., Price, D. B., Prokopakis, E. P., et al. (2018) · Clinical Otolaryngology · doi:10.1111/coa.13184 · Cited by 7
“tion of regulatory T cells, the change of antibody isotypes, among others.(6) The promise of AIT is multiple and resides in its ability to”
BackgroundWhat Do We Really Know About Intralymphatic Immunotherapy?
Klimek, L., Senti, G., Hoffmann, H. J., & Kündig, T. M. (2018) · Current Treatment Options in Allergy · doi:10.1007/s40521-018-0180-6 · Cited by 3
Metadata
- Authors
- Akdis, C. A., & Akdis, M.
- Affiliations
- Swiss Institute of Allergy and Asthma Research (SIAF), Obere Strasse 22, CH-7270 Davos Platz, Switzerland.
- Venue
- Science Translational Medicine
- Published
- 2015-03-25
- Volume
- 7
- Issue
- 280
- Pages
- 280ps6-280ps6
- ISSN
- 1946-6234 (ISSN-L)
- 1946-6242
- OpenAlex
- W2150757807
- Cited by
- 118
- References
- 55
- Citations by year
- 2026: 5 · 2025: 2 · 2024: 4 · 2023: 6 · 2022: 6 · 2021: 7 · 2020: 5 · 2019: 16 · 2018: 24 · 2017: 24 · 2016: 12 · 2015: 7
- FWCI
- 3.05
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science Translational Medicine (publishedVersion)
- PubMed (publishedVersion)
- Zurich Open Repository and Archive (University of Zurich) (acceptedVersion)
- Zurich Open Repository and Archive (University of Zurich) (submittedVersion)
- Funders
- European Commission's Seventh Framework Programme (261357 (MeDALL))
- European Commission's Seventh Framework (260895 (PREDICTA))
- Swiss National Science Foundation (310030_156823, 320030-140772)
- Topics
- Health Sciences › Medicine › Immunology and Allergy › Allergic Rhinitis and Sensitization
- Health Sciences › Medicine › Immunology and Allergy › Food Allergy and Anaphylaxis Research
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Asthma and respiratory diseases
- Keywords
- allergen immunotherapy, allergen tolerance, allergic diseases, T cell response, B cell response, antibody isotypes, eosinophils, mast cells, basophils, treatment standardization, treatment efficacy and safety
- MeSH terms
- Allergens, Animals, Humans, Immune Tolerance, Immunotherapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.